Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Most States Have Rules for Unwanted Drug Disposal, But Few Provide Funding
06/16/2022
“Most states have passed a statute relating to drug disposal from the general public as of May 2022, and their characteristics varied widely,” wrote study authors.
“Most states have passed a statute relating to drug disposal from the general public as of May 2022, and their characteristics varied widely,” wrote study authors.
“Most states have passed a...
06/16/2022
Pharmacy Learning Network
News
Pharmacist-Led Antiretroviral Stewardship Program Cuts Errors by One-Third
06/16/2022
Findings showed the number of uncorrected antiretroviral therapy errors was significantly reduced by a pharmacist-led antiretroviral stewardship program.
Findings showed the number of uncorrected antiretroviral therapy errors was significantly reduced by a pharmacist-led antiretroviral stewardship program.
Findings showed the number of...
06/16/2022
Pharmacy Learning Network

Advertisement

News
Eye Drops Recalled
06/16/2022
A prescription medication used to treat signs and symptoms of dry eye disease is being voluntarily recalled by Novartis Pharmaceuticals Corporation.
A prescription medication used to treat signs and symptoms of dry eye disease is being voluntarily recalled by Novartis Pharmaceuticals Corporation.
A prescription medication used...
06/16/2022
Pharmacy Learning Network
News
Blood Pressure Tablets Recalled
06/10/2022
Strides Pharma Inc is voluntarily recalling lots of prescription blood pressure tablets that failed to meet azido impurity levels.
Strides Pharma Inc is voluntarily recalling lots of prescription blood pressure tablets that failed to meet azido impurity levels.
Strides Pharma Inc is...
06/10/2022
Pharmacy Learning Network
News
Mouthwash Recalled
06/10/2022
A Class II recall has been issued for bottles of mouthwash due to a product complaint for milky blue appearance and consistency.
A Class II recall has been issued for bottles of mouthwash due to a product complaint for milky blue appearance and consistency.
A Class II recall has been...
06/10/2022
Pharmacy Learning Network

Advertisement

News
Over 2 Million Syringes, IV Bags Recalled for Lack of Sterility Assurance
06/09/2022
Nephron Sterile Compounding Center LLC issued recalls for more than 2.1 million syringes and IV bags containing a variety of compounds.
Nephron Sterile Compounding Center LLC issued recalls for more than 2.1 million syringes and IV bags containing a variety of compounds.
Nephron Sterile Compounding...
06/09/2022
Pharmacy Learning Network
News
Pandemic Linked to Racial, Ethnic Disparities in Buprenorphine Fill Rates
06/08/2022
The pandemic may have exacerbated disparities for members of racial and ethnic minority groups seeking to fill buprenorphine prescriptions, research shows.
The pandemic may have exacerbated disparities for members of racial and ethnic minority groups seeking to fill buprenorphine prescriptions, research shows.
The pandemic may have...
06/08/2022
Pharmacy Learning Network
News
ADHD Patches Recalled
06/02/2022
A Class II recall has been issued for prescription patches used for treating patients with ADHD.
A Class II recall has been issued for prescription patches used for treating patients with ADHD.
A Class II recall has been...
06/02/2022
Pharmacy Learning Network

Advertisement

News
More Firms Recall Blood Pressure Tablets
06/02/2022
More voluntary recalls have been issued for blood pressure tablets because of azido impurity levels above acceptable limits.
More voluntary recalls have been issued for blood pressure tablets because of azido impurity levels above acceptable limits.
More voluntary recalls have been...
06/02/2022
Pharmacy Learning Network
News
HIV Tablets Recalled
06/02/2022
GlaxoSmithKline is voluntarily recalling a prescription antiretroviral medication due to an incorrect expiration date.
GlaxoSmithKline is voluntarily recalling a prescription antiretroviral medication due to an incorrect expiration date.
GlaxoSmithKline is voluntarily...
06/02/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use